Business

New Development Aims to Detect Tumor Infiltration

New Development Aims to Detect Tumor Infiltration.

articleImaging Biometrics LimitedJuly 10, 20203/company/imaging-biometrics-limited/news/new-development-aims-to-detect-tumor-infiltration
New Development Aims to Detect Tumor Infiltration

About this update from Imaging Biometrics Limited

[{"type":"text","content":"\n \n \n RNS Number : 5973S\n IQ-AI Limited\n 10 July 2020\n  \n \n \n \n IQ-AI Ltd\n \n \n (\"IQ-AI\" or the \"Company\")\n \n \n New Development Aims to Detect Tumor Cell Infiltration\n \n \n  \n \n \n On the 19\n \n th\n \n June, \n t\n he \n IQ\n -AI \n Board \n announced \n it was \n exploring a \n number of \n new initiative\n s\n and\n are \n looking at the wider\n  application of IB technology and products. \"IB CAD\" is the first of such new developments.\n \n \n  \n \n \n IQ-AI Limited (LON:IQAI)\n and its subsidiary Imaging Biometrics, LLC\n  \n (IB) has commenced the development of a cancer imaging technology, \"IB CAD\",that will \n detect cancer cells\n \n before they are visible on standard imaging.\n \n  \n \n \n  \n \n \n By combiningmulti-parameter magnetic resonance (MR) data and leveraging artificial intelligence (AI) algorithms,IB CAD willprovide a structured way in which infiltrating tumor cells can be identified. In effect,IB CADwill have the potential to \n detect\n \n  \n \n andidentify sites of infiltrating tumor growth not visible with current imaging methods. IB CADhas the potential to detect tumor cells in non-contrast enhancing regions, thus providing the ultimate in early detection, a key advancement forcancer treatment. This technology has the potential to disrupt the way surgery is performed, how radiation treatments are planned, and how treatment therapy is assessed. \n \n \n  \n \n \n Most brain tumor patients \n will undergo surgical resection with post-surgical therapy. \n T\n he survival rates for these patients \n improve when more of the\n original tumor\n can be\n removed during surgery. \n For this reason,N\n eurosurgeons will \n usually\n remove neighboring\n  \n tissue or \"margins\"\n that may otherwise appear healthy using current imaging techniques. In cases where the tumor has infiltrated eloquent cortex (areas of the brain that impact basic human functions such as speech, vision, motor skills or cognitive abilities), the removal of safe margins may be limited. In those cases, r\n esidual tumor\n  \n remains\n and may not receive proper treatment until it grows large enough to be detected with current imaging. While advancements in radiotherapy treatment systems have surpassed the primitative imaging methods currently...

More updates from Imaging Biometrics Limited